Literature DB >> 30037292

Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib.

Kaelyn C Cummins1,2, Matthew P Cheng1,2,3, David W Kubiak2,3, Matthew S Davids2,3, Francisco M Marty1,2,3, Nicolas C Issa1,2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30037292     DOI: 10.1080/10428194.2018.1485913

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  5 in total

1.  Invasive Aspergillosis in Patients Treated With Ibrutinib.

Authors:  Moritz Fürstenau; Florian Simon; Oliver A Cornely; Tillman Hicketier; Barbara Eichhorst; Michael Hallek; Sibylle C Mellinghoff
Journal:  Hemasphere       Date:  2020-02-13

Review 2.  A Systematic Review to Assess the Relationship between Disseminated Cerebral Aspergillosis, Leukemias and Lymphomas, and Their Respective Therapeutics.

Authors:  Brianne N Sullivan; Mia A Baggett; Samantha S O'Connell; Keith M Pickett; Chad Steele
Journal:  J Fungi (Basel)       Date:  2022-07-11

3.  Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature.

Authors:  Jessica S Little; Matthew P Cheng; Liangge Hsu; C Eduardo Corrales; Francisco M Marty
Journal:  Open Forum Infect Dis       Date:  2019-09-05       Impact factor: 3.835

4.  When to change treatment of acute invasive aspergillosis: an expert viewpoint.

Authors:  Monica A Slavin; Yee-Chun Chen; Catherine Cordonnier; Oliver A Cornely; Manuel Cuenca-Estrella; J Peter Donnelly; Andreas H Groll; Olivier Lortholary; Francisco M Marty; Marcio Nucci; John H Rex; Bart J A Rijnders; George R Thompson; Paul E Verweij; P Lewis White; Ruth Hargreaves; Emma Harvey; Johan A Maertens
Journal:  J Antimicrob Chemother       Date:  2021-12-24       Impact factor: 5.790

Review 5.  On point in primary CNS lymphoma.

Authors:  Mazie Tsang; Joseph Cleveland; James L Rubenstein
Journal:  Hematol Oncol       Date:  2020-07-03       Impact factor: 5.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.